Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma
暂无分享,去创建一个
N. Sharma | P. Fu | M. Yao | M. Machtay | M. Gibson | R. Rezaee | P. Lavertu | J. Wasman | C. Woods | C. Zender | P. Savvides